Patents by Inventor Jean Dubayle

Jean Dubayle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILA
    Publication number: 20230346913
    Abstract: Recombinant expression of influenza virus surface proteins in the fungus Myceliophthora thermophila strain C1 is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Application
    Filed: July 11, 2023
    Publication date: November 2, 2023
    Applicant: DYADIC INTERNATIONAL INC.
    Inventors: Mark EMALFARB, Teunis Cornelis Verwoerd, Mark R. Alfenito, Mark Baer, Isabelle Legastelois, Marie-Pierre Kazek, Marie-Clotilde Bernard, Jean Dubayle, Richard Kensinger
  • Production of flu vaccine in
    Patent number: 11738080
    Abstract: Recombinant expression of influenza virus surface proteins in the fungus Myceliophthora thermophila strain C1 is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: August 29, 2023
    Assignee: DYADIC INTERNATIONAL INC.
    Inventors: Mark Emalfarb, Teunis Cornelis Verwoerd, Mark R. Alfenito, Mark Baer, Isabelle Legastelois, Marie-Pierre Kazek, Marie-Clotilde Bernard, Jean Dubayle, Richard Kensinger
  • PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILA
    Publication number: 20200215183
    Abstract: Recombinant expression of influenza vims surface proteins in the fungus Myceliophthora thermophila strain Cl is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Application
    Filed: August 9, 2018
    Publication date: July 9, 2020
    Inventors: Mark EMALFARB, Teunis Cornelis VERWOERD, Mark R. ALFENITO, Mark BAER, Isabelle LEGASTELOIS, Marie-Pierre KAZEK, Marie-Clotilde BERNARD, Jean DUBAYLE, Richard KENSINGER
  • Chemically modified hiv envelope glycoprotein
    Publication number: 20030099934
    Abstract: The present invention relates to an envelope glycoprotein of HIV in purified form which can be obtained by a method comprising the following steps: (1) production of an envelope glycoprotein in purified form, (2) reduction of at least one disulfide bridge of the glycoprotein of step (1), (3) alkylation of at least two free sulfhydryl groups, (4) optionally, oxidation of the remaining free sulfhydryl groups, (5) denaturation and (6) renaturation, and to its use in a vaccine against HIV which can be used for inducing antibodies which neutralize HIV in a human individual, therapeutically or prophylactically.
    Type: Application
    Filed: November 18, 2002
    Publication date: May 29, 2003
    Inventors: Florence Boudet, Michel Chevalier, Jean Dubayle, Raphaelle El Habib